SPAC977.14c Antibody

What is SPAC977.14c and why is it studied in Schizosaccharomyces pombe research?

SPAC977.14c is classified as an aldo/keto reductase with currently unknown biological roles in Schizosaccharomyces pombe (fission yeast) . The protein has been identified through proteomic analysis and is of interest due to its dual localization in both the cytosol and nucleus, as determined by immunodetection methods and GO Component analysis . Aldo/keto reductases typically catalyze the reduction of various carbonyl-containing compounds, suggesting SPAC977.14c may play roles in metabolic processes or stress responses. Studying SPAC977.14c contributes to our understanding of fission yeast biology, particularly regarding redox metabolism and potentially stress response pathways.

What are the critical specifications to consider when selecting a SPAC977.14c antibody?

When selecting a SPAC977.14c antibody, researchers should consider several critical specifications:

• Antibody Type: Currently available as polyclonal antibodies raised in rabbits against recombinant Schizosaccharomyces pombe (strain 972/ATCC 24843) SPAC977.14c protein .

• Species Reactivity: Specifically reactive with S. pombe (strain 972/ATCC 24843), with limited cross-reactivity to other species .

• Validated Applications: Confirmed applications typically include ELISA and Western blotting (WB), though researchers should verify if the antibody has been validated for their specific application of interest .

• Purification Method: Antigen affinity purified antibodies offer better specificity compared to crude serum preparations .

• Storage Buffer Composition: Typically preserved in 0.03% Proclin 300 with 50% Glycerol in 0.01M PBS, pH 7.4, which affects stability and functional activity .

• Formulation: Available in liquid form, non-conjugated, which requires appropriate secondary antibodies for detection systems .

What are the recommended handling and storage conditions for SPAC977.14c antibodies?

For optimal performance and longevity of SPAC977.14c antibodies, the following handling and storage conditions are recommended:

• Storage Temperature: Store at -20°C or preferably -80°C upon receipt to maintain activity and prevent degradation .

• Freeze-Thaw Cycles: Avoid repeated freeze-thaw cycles as they can lead to denaturation and loss of antibody activity. Aliquot the antibody into smaller volumes before freezing if multiple uses are anticipated .

• Working Temperature: Keep antibodies on ice during experimental procedures and return to appropriate storage promptly after use.

• Buffer Conditions: The antibody is typically supplied in a storage buffer containing 50% glycerol, 0.01M PBS, pH 7.4, with 0.03% Proclin 300 as a preservative. This formulation helps maintain stability during freeze-thaw cycles .

• Dilution Storage: Once diluted for use, store at 4°C for short-term use (1-2 weeks). For longer storage, prepare fresh dilutions from frozen stock aliquots.

• Contamination Prevention: Use clean, nuclease-free pipette tips and tubes to prevent contamination. Consider adding additional preservatives for diluted antibody solutions if they will be stored for extended periods.

How should researchers validate the specificity of SPAC977.14c antibodies for their experiments?

Validating antibody specificity is critical for ensuring experimental reliability. For SPAC977.14c antibodies, implement the following validation approaches:

Strategy 1: Knockout/Knockdown Controls

• Test antibody reactivity in wild-type S. pombe compared to strains where SPAC977.14c has been deleted or silenced.

• A genuine antibody will show signal in wild-type samples but reduced or absent signal in knockout/knockdown samples .

Strategy 2: Orthogonal Detection Methods

• Compare antibody detection patterns with orthogonal methods such as mass spectrometry or RNA expression analysis.

• Correlation between protein detection by antibody and mRNA levels provides supporting evidence for specificity .

Strategy 3: Multiple Antibodies Approach

• When possible, use multiple antibodies targeting different epitopes of SPAC977.14c.

• Consistent detection patterns across different antibodies increase confidence in specificity .

Strategy 4: Immunoprecipitation-Mass Spectrometry

• Perform immunoprecipitation with the SPAC977.14c antibody followed by mass spectrometry.

• This approach identifies all proteins pulled down by the antibody, confirming target enrichment and revealing potential cross-reactivity .

Strategy 5: Recombinant Protein Competition

• Pre-incubate the antibody with purified recombinant SPAC977.14c protein before application.

• Specific signal should be reduced or eliminated by this competitive binding approach .

Strategy 6: Western Blot Analysis

• The antibody should detect a band of the expected molecular weight for SPAC977.14c.

• Multiple or unexpected bands may indicate cross-reactivity with other proteins .

What are the optimal protocols for Western blot detection of SPAC977.14c?

For optimal Western blot detection of SPAC977.14c, researchers should follow this methodological approach:

Sample Preparation:

• Harvest S. pombe cells in mid-log phase growth (OD600 ~0.5-0.8).

• For total protein extraction, use a buffer containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 5 mM EDTA, supplemented with protease inhibitors.

• Disrupt cells using glass beads (0.5 mm) with a cell disruptor (8 cycles of 30 seconds on/30 seconds off on ice) .

• Clarify lysate by centrifugation at 14,000×g for 15 minutes at 4°C.

SDS-PAGE Separation:

• Load 20-50 μg of total protein per lane.

• Use a 10-12% polyacrylamide gel for optimal resolution of SPAC977.14c.

• Include molecular weight markers and positive/negative controls.

Transfer and Blocking:

• Transfer proteins to PVDF membrane (0.45 μm) at 100V for 1 hour in cold transfer buffer.

• Block membrane with 5% non-fat dry milk in TBST (TBS + 0.1% Tween-20) for 1 hour at room temperature.

Antibody Incubation:

• Dilute SPAC977.14c primary antibody at 1:1000 to 1:2000 in blocking buffer.

• Incubate membrane overnight at 4°C with gentle agitation.

• Wash 3-5 times with TBST, 5 minutes each.

• Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000) for 1 hour at room temperature.

• Wash 5 times with TBST, 5 minutes each.

Detection:

• Apply ECL substrate and detect signal using a digital imaging system.

• For quantitative analysis, use a range of exposure times to ensure signal is within linear range.

Troubleshooting Considerations:

• High background: Increase washing times/frequency or decrease antibody concentration.

• No signal: Check protein transfer efficiency, increase antibody concentration, or extend exposure time.

• Multiple bands: Optimize lysis conditions to prevent protein degradation, or evaluate antibody specificity .

How can SPAC977.14c antibodies be utilized in chromatin fractionation studies?

SPAC977.14c has been identified in both nuclear and cytosolic compartments, making chromatin fractionation studies particularly relevant. Here's a methodological approach:

Chromatin Fractionation Protocol:

• Cell Preparation:

  • Grow S. pombe cells to mid-log phase (OD600 0.5-0.8)

  • Harvest and wash cells with cold PBS

• Spheroplasting:

  • Resuspend cells in spheroplasting buffer (1.2 M sorbitol, 20 mM HEPES, pH 7.4)

  • Add Zymolyase (1 mg/ml) and incubate at 30°C until 90% of cells become spheroplasts

• Fractionation Procedure:

  • Lyse spheroplasts in buffer containing 18% Ficoll 400, 20 mM HEPES pH 7.4, 0.5 mM MgCl2, plus protease and phosphatase inhibitors

  • Centrifuge at 16,000×g for 30 minutes to separate chromatin-bound (pellet) from non-chromatin (supernatant) proteins

• Extraction of Chromatin-Bound Proteins:

  • Resuspend chromatin pellet in high-salt extraction buffer (50 mM Tris-HCl pH 7.5, 600 mM NaCl, 1% Triton X-100, 0.1% sodium deoxycholate)

  • Sonicate briefly (3 × 10s pulses at 40% amplitude)

  • Centrifuge at 16,000×g for 10 minutes and collect supernatant containing extracted chromatin proteins

• Validation Controls:

  • Confirm fractionation quality by probing for known chromatin markers (e.g., histones) and cytoplasmic markers (e.g., tubulin)

  • Process samples for western blotting as described in section 2.2

Analysis Considerations:

• In quantitative analysis, calculate the chromatin association ratio by comparing SPAC977.14c levels in chromatin fraction versus total extract

• SILAC-based proteomic approaches can provide additional quantitative information about chromatin association

• For dynamic studies, compare chromatin association under different growth conditions or cell cycle stages

What are the considerations for performing immunoprecipitation with SPAC977.14c antibodies?

Immunoprecipitation (IP) with SPAC977.14c antibodies requires careful optimization. Here's a comprehensive methodological approach:

Immunoprecipitation Protocol:

• Lysate Preparation:

  • Harvest 50-100 ml of S. pombe culture (OD600 ~0.8)

  • Wash cells with cold PBS and resuspend in IP lysis buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, with protease inhibitors)

  • Lyse cells using glass beads with a cell disruptor (8 cycles of 30s on/30s off)

  • Clear lysate by centrifugation at 14,000×g for 15 minutes at 4°C

  • Pre-clear lysate with Protein A/G beads for 1 hour at 4°C to reduce non-specific binding

• Antibody Binding:

  • Add 2-5 μg of SPAC977.14c antibody to 500-1000 μg of protein lysate

  • Incubate overnight at 4°C with gentle rotation

  • Add 40 μl of Protein A/G magnetic beads and incubate for 2-3 hours at 4°C

• Washing and Elution:

  • Wash beads 5 times with IP wash buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.1% Triton X-100)

  • For protein interaction studies, use a more stringent final wash (with 300 mM NaCl)

  • Elute bound proteins by boiling in 40 μl of 2X SDS sample buffer for 5 minutes

• Control Experiments:

  • Include a negative control with non-specific IgG from the same species as the primary antibody

  • Use lysate from SPAC977.14c deletion strain as an additional specificity control

Special Considerations:

• For studying protein complexes involving SPAC977.14c, consider crosslinking cells with 1% formaldehyde before lysis

• For phosphorylation studies, include phosphatase inhibitors in all buffers and consider using phos-tag gels for separation

• For detecting transient interactions, try using a two-step tandem affinity purification approach as described in literature

• For mass spectrometry analysis, elute with non-denaturing conditions using peptide competition or mild acid elution

How can researchers troubleshoot weak or non-specific signals when using SPAC977.14c antibody?

When encountering weak or non-specific signals with SPAC977.14c antibody, employ this systematic troubleshooting approach:

Problem 1: Weak or No Signal

Problem 2: High Background or Non-specific Bands

Problem 3: Inconsistent Results

Advanced Optimization Techniques:

• Try signal enhancement systems compatible with HRP detection

• Consider using lysate fractionation to enrich for nuclear or cytosolic pools

• For critical quantitative applications, validate results with orthogonal methods (e.g., mass spectrometry)

What are the considerations for using SPAC977.14c antibody in chromatin immunoprecipitation (ChIP) experiments?

While ChIP is not listed among the validated applications for existing SPAC977.14c antibodies, researchers interested in exploring potential chromatin interactions would need to consider the following methodological approach:

ChIP Protocol Optimization for SPAC977.14c:

• Cross-linking Optimization:

  • Test different cross-linking conditions, starting with 1% formaldehyde for 10 minutes at room temperature

  • For proteins with indirect DNA association, consider using protein-protein crosslinkers like DSG (disuccinimidyl glutarate) before formaldehyde

• Chromatin Preparation:

  • Optimize sonication conditions to generate DNA fragments of 200-500 bp

  • Confirm fragmentation efficiency by reverse cross-linking a small aliquot and analyzing DNA size by agarose gel electrophoresis

  • Pre-clear chromatin with Protein A/G beads to reduce background

• Immunoprecipitation Considerations:

  • Use 3-5 μg of antibody per ChIP reaction for initial testing

  • Include appropriate controls: IgG negative control and a positive control antibody targeting known chromatin-associated proteins (e.g., histones)

  • Extend incubation time to overnight at 4°C with gentle rotation to maximize immunoprecipitation efficiency

• Washing and Elution:

  • Use increasingly stringent wash buffers to reduce non-specific binding

  • Elute chromatin complexes with elution buffer containing 1% SDS and 0.1 M NaHCO₃

  • Reverse cross-links overnight at 65°C followed by proteinase K treatment

• Detection and Analysis:

  • For ChIP-qPCR, design primers for genomic regions of interest based on known aldo/keto reductase binding sites

  • For ChIP-seq, confirm immunoprecipitation efficiency by qPCR before library preparation

Special Considerations:

• Since SPAC977.14c is an aldo/keto reductase with unknown DNA-binding capabilities, consider the possibility that it may interact with chromatin indirectly through protein complexes

• Validate ChIP results with reciprocal ChIP using antibodies against suspected interaction partners

• For novel associations, perform ChIP-mass spectrometry to identify co-precipitating proteins

How does SPAC977.14c relate functionally to other aldo/keto reductases, and what implications does this have for experimental design?

SPAC977.14c belongs to the aldo/keto reductase family, with potential functional relationships that impact experimental design:

Functional Relationships and Homology:

Aldo/keto reductases (AKRs) constitute a superfamily of enzymes that catalyze the NADPH-dependent reduction of various carbonyl-containing substrates. While the specific function of SPAC977.14c remains uncharacterized, functional analysis can be informed by homology to other AKRs.

• Evolutionary Conservation:

  • AKRs are evolutionarily conserved from yeast to humans, suggesting fundamental metabolic roles

  • SPAC977.14c likely shares the core AKR fold consisting of a TIM barrel structure with a conserved catalytic tetrad (Asp, Tyr, Lys, His)

• Potential Functional Roles:

  • Based on other characterized AKRs, SPAC977.14c may function in:

    • Stress response (oxidative or osmotic stress)

    • Secondary metabolism

    • Redox homeostasis

    • Detoxification of reactive aldehydes

Experimental Design Implications:

• Substrate Identification Studies:

  • Design experiments to test SPAC977.14c activity against common AKR substrates (aldehydes, ketones, glucose)

  • Consider using recombinant protein and in vitro enzyme assays with NADPH consumption measurement

  • Create activity profiles under different physiological conditions

• Functional Redundancy Considerations:

  • Identify other AKRs in S. pombe genome that may have overlapping functions

  • Consider creating double or triple knockouts to overcome functional redundancy

  • Use comparative proteomics to identify compensatory changes in expression of other AKRs

• Localization-Specific Functions:

  • Given SPAC977.14c's dual localization (cytosol and nucleus), design compartment-specific experiments

  • Use tagged variants with nuclear export or localization signals to restrict localization

  • Compare function in each compartment using subcellular fractionation methods

• Stress Response Studies:

  • Test SPAC977.14c expression and localization under various stress conditions:

    • Oxidative stress (H₂O₂, menadione)

    • Heavy metal exposure (cadmium, as in studies of other S. pombe proteins)

    • Osmotic stress

    • Nutrient limitation

• Protein Interaction Network Analysis:

  • BioGRID database indicates SPAC977.14c has 5 known interactors

  • Design co-immunoprecipitation experiments to validate these interactions

  • Consider using proximity labeling approaches (BioID, APEX) to identify compartment-specific interaction partners

What are the considerations for using SPAC977.14c antibodies in fluorescence microscopy studies?

Fluorescence microscopy with SPAC977.14c antibodies requires careful optimization, especially given its dual localization in both cytosol and nucleus:

Immunofluorescence Protocol Optimization:

• Fixation Method Selection:

  • Compare different fixation methods: methanol (-20°C, 6 min) for structural proteins vs. paraformaldehyde (4%, 15 min) for better epitope preservation

  • For SPAC977.14c, which localizes to both cytosol and nucleus, start with 3.7% formaldehyde fixation for 30 minutes at room temperature

• Cell Wall Digestion:

  • S. pombe requires cell wall digestion for antibody accessibility

  • Use Zymolyase (1 mg/ml in sorbitol buffer) until 90% of cells become spheroplasts (typically 30-60 minutes)

  • Monitor spheroplasting by microscopy to prevent over-digestion

• Permeabilization Optimization:

  • Test different permeabilization agents: 0.1% Triton X-100 (5 min), 0.5% Saponin (30 min), or -20°C methanol (6 min)

  • For dual-localized proteins like SPAC977.14c, a combination of mild detergent treatment followed by methanol permeabilization may provide optimal results

• Blocking Conditions:

  • Block with 5% BSA in PBS for 1 hour at room temperature

  • Include 0.1% Tween-20 in blocking buffer to reduce background

  • For problematic samples, consider using 10% normal serum from the same species as the secondary antibody

• Antibody Incubation:

  • Determine optimal primary antibody dilution (starting with 1:100 to 1:500)

  • Incubate overnight at 4°C in a humidified chamber

  • Use fluorophore-conjugated secondary antibodies at 1:500 to 1:1000 dilution

• Co-localization Studies:

  • Include markers for nuclear envelope (anti-Nup107) and nucleoplasm (DAPI staining)

  • Consider co-staining with markers for specific nuclear compartments (nucleolus, chromatin)

  • Use super-resolution microscopy techniques for precise localization studies

Quantitative Analysis Approaches:

• Measure nuclear/cytoplasmic ratio under different conditions to study translocation events

• Use deconvolution or confocal microscopy for improved resolution

• Apply automated image analysis for unbiased quantification

Validation Controls:

• Include negative controls (primary antibody omission, isotype control)

• Use SPAC977.14c deletion strain as specificity control

• Validate localization with orthogonal methods (e.g., GFP-tagged SPAC977.14c)

What are the advantages and limitations of using polyclonal versus monoclonal antibodies for SPAC977.14c research?

Understanding the trade-offs between polyclonal and monoclonal antibodies is crucial for experimental design in SPAC977.14c research:

Comparative Analysis of Antibody Types for SPAC977.14c Research:

Methodological Recommendations:

• For Initial Characterization Studies:

  • Polyclonal antibodies offer advantages for first-time detection of native SPAC977.14c

  • They provide higher sensitivity when protein expression levels are unknown

  • Better tolerance for varying experimental conditions during protocol optimization

• For Quantitative Studies:

  • Consider developing monoclonal antibodies for consistent quantification

  • If using polyclonals, implement rigorous lot testing and standardization

  • Include recombinant SPAC977.14c standards for calibration curves

• For Specific Applications:

  • Chromatin Studies: Polyclonals may offer advantages for ChIP by recognizing multiple epitopes

  • Structural Studies: Monoclonals would provide more defined epitope binding

  • Proximity Labeling: Monoclonals would offer more precise spatial information

• For Evolutionary Studies Across Species:

  • Polyclonals may recognize conserved epitopes across related species

  • Monoclonals would provide higher specificity for S. pombe-specific regions

Future Directions:

• Consider developing recombinant antibodies (e.g., single-chain variable fragments) for improved reproducibility

• Evaluate nanobodies as alternatives for certain applications where size matters

• For critical studies, validate results with multiple antibody clones targeting different regions of SPAC977.14c